Skip to main content
Log in

Memantine of value for Alzheimer's disease

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Weycker D, Taneja C, Edelsberg J, Erder MH, Schmitt FA, Setyawan J, Oster G.Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil. Current Medical Research and Opinion 23: 1187-1197, No. 5, May 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Memantine of value for Alzheimer's disease. Pharmacoecon. Outcomes News 531, 1 (2007). https://doi.org/10.2165/00151234-200705310-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705310-00001

Keywords

Navigation